Profile of metabolic abnormalities seen in patients with type 2 diabetes mellitus and their first degree relatives with metabolic syndrome seen in Benin City, Edo state Nigeria

Journal of Diabetes & Metabolic Disorders

Ignatius U Ezeani¹  Stephen O Ogedengbe¹ 

[1] Departments of Medicine, University of Benin Teaching Hospital, Benin City and Federal Medical Center, P.M.B 7001, Umuahia, Abia state, Nigeria

关键词: Dyslipidemia;    Obesity;    Hypertension;    Anthropometry;    Type 2 diabetes mellitus;    Biochemical abnormalities;    Metabolic syndrome;   

Others  :  803437
DOI  :  10.1186/2251-6581-13-61

 received in 2013-10-16, accepted in 2014-05-02,  发布年份 2014

【 摘 要 】

Background

To determine the profile of metabolic abnormalities in T2DM persons with metabolic syndrome and their non-diabetic first-degree relatives who also had metabolic syndrome in Benin City.

Methodology

This was a cross sectional case controlled study in which convenience sampling technique was used to recruit 106 persons with T2DM, 96 people who are first degree relatives of type 2 diabetic persons and 96 controls using a interviewer administered questionnaire technique. The following were assessed: anthropometric indices, blood pressure, serum lipid profile, fasting blood sugar, proteinuria, and microalbuminuria. The data obtained were analyzed using the statistical software-Statistical package for social sciences [SPSS] version 16. A p-value of less than 0.05 was taken as statistically significant.

Results

The mean age (SD) of the study groups were: persons living with T2DM: 58.6 ± 11.2 years, control: 57.69 ± 60.8 years and FDR: 57.4 ± 10.6 years. No significant age and sex differences were observed in these groups. There were more females (59.7%) than males (40.3%) with T2DM. The prevalence of MS was 13.5%, 16.7%, and 87.1% in the control, FDR and T2DM patients respectively. For the T2DM group of subjects, impaired fasting glycaemia was the commonest metabolic abnormality followed by microalbuminuria, low HDL cholesterol, high LDL cholesterol, hypercholesterolaemia and hypertriglyceridaemia in decreasing frequency. For the FDR group, low HDL cholesterol was the commonest metabolic abnormality followed by hypertriglyceridaemia, impaired fasting glucose, high LDL cholesterol, hypertriglyceridaemia and microalbuminuria in decreasing frequency. Hypercholesterolemia and low HDL cholesterol were the commonest metabolic abnormalities in the control group.

Conclusion

The prevalence of the MS in persons with T2DM in Nigeria appears to be high. Secondly, there is a high prevalence of lipid abnormalities in all the study groups.

【 授权许可】

   
2014 Ogedengbe and Ezeani; licensee BioMed Central Ltd.

【 图 表 】

Figure 2.

Figure 3.

【 参考文献 】

• [1]Reaven GM: Role of insulin resistance in human disease. Diabetes 1989, 37:1595-1607.
• [2]The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/idf_meta_def_final.pdf. Accessed on the 6th of November, 2008
• [3]Alberti KG, Zimmet P, Shaw J: IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005, 366:1059-1062.
• [4]Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
• [5]Kaplan NM: The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridaemia and hypertension. Arch Intern Med 1989, 149:1514-1520.
• [6]The Metabolic Syndrome, WHO criteria. www.staff.ncl.ac.uk/Philip. home/who_dgm.pdf Accessed on 24th March, 2009
• [7]Zimmet P, Alberti G, Shaw J: A new IDF worldwide definition of the metabolic syndrome: the rationale and the results. Diabetes Voice 2005, 50(3):31-33. http://www.diabetesvoice.org/files/attachments/article_361_en.pdf webcite. Accessed on 24th March, 2009
• [8]Alberti KG, Zimmet P, Shaw J: Metabolic syndrome – a new world wide definition. A Consensus Statement from the International Diabetes Federation. Diabetes Med 2006, 23:460-469.
• [9]Stewart MW, Humphriss DB, Berrish TS, et al.: Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care 1995, 18:1020-2.
• [10]Gulli G, Ferrannini E, Stern M, Steven H, Defronzo RA: The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 1992, 41:1575-86.
• [11]Elbein SC, Maxwell TM, Schumacher MC: Insulin and glucose levels and prevalence of glucose intolerance in pedigrees with multiple diabetic siblings. Diabetes 1991, 40:1024-32.
• [12]Carmelli D, Cardon LR, Fabsitz R: Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environments? Am J Hum Genet 1994, 55:566-73.
• [13]Zimmet P, Hodge A, Nicolson M, Myrlene S, Maximilian C, Jason M, Morawiecki A, Lubina J, Collier G, Alberti G, Dowse G: Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. BMJ 1996, 313:965-969.
• [14]Porte D Jr: Mechanisms for hyperglycemia in the metabolic syndrome. The key role of beta-cell dysfunction. Ann N Y Acad Sci 1999, 892:73-83.
• [15]Mitchell BD, Haffner SM, Hazuda HP, Valdez R, Stern MP: The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. Am J Epidemiol 1992, 136:12-22.
• [16]Hales CN, Barker DJ: Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992, 35:595-601.
• [17]Ogbera AO: Prevalence and gender distribution of the metabolic syndrome. Diabetology & Metabolic Syndrome 2010, 2:1. doi:10.1186/1758-5996-2-1 BioMed Central Full Text
• [18]Alebiosu OC, Odusan BO: Metabolic syndrome in subjects with type 2 diabetes mellitus. J Natl Med Assoc 2004, 96(6):817-821.
• [19]Nyenwe EA, Odia OJ, Ihekwaba AE, Ojule A, Babatunde S: Type 2 Diabetes in Adult Nigerians: Study of its prevalence and risk factors in Port-Harcourt, Nigeria. Diabetes Res Clin Pract 2003, 62:177-185.
• [20]Eregie A, Edo A: Diagnosing the metabolic syndrome: A comparative evaluation of three Diagnostic tools Poster presentation. 19th World Diabetes Congress, International Diabetes Federation. December 3rd-7th, 2006 Cape Town, South Africa. Diabet Med 2006, 23(4):732.
• [21]Adediran OS, Ohwovoriole AE: Prevalence of the metabolic syndrome among Nigerians with type 2 diabetes mellitus. Paris, France: Poster presentation, 18th International Diabetes Federation Congress on Diabetes Metabolism; 2003:4s30-4s31.
• [22]Wannamethee SG, Shaper AG, Perry IJ: Smoking as a modifiable risk factor for type 2 diabetes mellitus. Diabetes Care 2001, 24(9):1590-5.
• [23]Sairenchi T, Iso H, Akio N: Cigarette smoking and type 2 diabetes mellitus among middle aged and elderly Japanese men and women. Am J Epidemiol 2004, 160:158-162.
• [24]Puepet FH, Ohwovoriole AE: Prevalence of risk factors for diabetes mellitus in a non-diabetic population in Jos,Nigeria. Niger J Med 2008, 17(1):71-4.
• [25]Lombrail P, Lang T, Durrieu A, Bernard JL, Betouigt H, Dupouy M, Font D, Viel E, Parant C, Vexiau P: Alcohol: an underscored risk factor for diabetes mellitus. Eur J Med 1992, 1(6):324-8.
• [26]Helmrich SP, Rapland DR, Leug RW: Physical activity and reduced occurrence of non-insulin dependent diabetes mellitus. N Eng J Med 1991, 235:147-152.
• [27]Karaman A, Bayram F, Gundogan K, Ozsan M, Karaman H, Kelestimur F: Prevalence of diabetes mellitus and glucose metabolism disorders in the first degree relatives of type 2 diabetic patients. Bratisl Lek Listy 2012, 113(6):361-7.
• [28]Ma H, Gong Y, Liu YY, Song J, Tian HM, Chen T, Ran XW: Prevalence of diabetes and prediabetes mellitus in the first-degree relatives of patients with type 2 diabetes in Chengdu. Sichuan Da Xue Xue Bao Yi Xue Ba 2011, 42(2):264-8.